0. DOCID:25916 SCORE: 0.00203200495167608
DOCNO: 10568682
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: adverse effects
QUALIFIER: adverse effects
QUALIFIER: drug therapy
QUALIFIER: chemically induced
AUTHOR: A Gurjal A
AUTHOR: T An T
AUTHOR: M Valdivieso M
AUTHOR: G P Kalemkerian GP
AFFILIATION: The Department of Internal Medicine, Wayne State University and the Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Lung cancer (Amsterdam, Netherlands)
COUNTRY: IRELAND
TITLE: Etoposide-induced pulmonary toxicity.
PUBDATE: 19991101
After treatment with etoposide, two patients with lung cancer developed interstitial infiltrates and respiratory failure. Of the two, one patient responded rapidly to steroid therapy and developed recurrent symptoms on re-challenge with etoposide. Both patients had histopathologic findings consistent with drug-induced pulmonary toxicity. Etoposide-induced lung disease needs to be considered in patients who develop subacute dyspnea and interstitial infiltrates during treatment with this agent.


1. DOCID:25944 SCORE: 0.0020320037097106
DOCNO: 9810418
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
AUTHOR: M Pawlicki M
AUTHOR: J Rolski J
AUTHOR: B Wiczyńska B
AUTHOR: U Rychlik U
AFFILIATION: Kliniki Chemioterapii Centrum Onkologii, Oddział w Krakowie.
PUBTYPE: Clinical Trial
PUBTYPE: Journal Article
JOURNALTITLE: Ginekologia polska.
COUNTRY: POLAND
TITLE: [Evaluation of efficacy and toxicity of PC chemotherapy (cisplatin, cyclophosphamide) administered with amifostine in patients with clinically advanced ovarian cancer]
PUBDATE: 19980701
Twenty patients with advanced ovarian cancer were treated with chemotherapy PC (cisplatin 100 mg/m2, cyclophosphamide 1000 mg/m2) administered with amifostine. Sixty five percent of patients had objective response with 25% complete response rate. Tolerance of treatment was satisfactory. Only in 1 patients side effects were the reason of treatment interruption. Amifostine markedly decreases chemotherapy toxicity, mainly hematological and does not seem to influence the efficacy of chemotherapy.


2. DOCID:26356 SCORE: 0.00169778629591597
DOCNO: 11090989
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Plants, Medicinal
QUALIFIER: therapy
AUTHOR: J G Graham JG
AUTHOR: M L Quinn ML
AUTHOR: D S Fabricant DS
AUTHOR: N R Farnsworth NR
AFFILIATION: Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, 833 South Wood Street, Chicago IL 60612, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Journal of ethnopharmacology.
COUNTRY: IRELAND
TITLE: Plants used against cancer - an extension of the work of Jonathan Hartwell.
PUBDATE: 20001201
A survey of plants used ethnomedically against cancer was undertaken, using the NAPRALERT database currently maintained by the Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois-Chicago. We report over 350 species which are reported to be used against cancer and not cited in the work of Jonathan Hartwell, "Plants used against cancer: a survey", including previously unrepresented genera and families.


3. DOCID:27161 SCORE: 0.00140502718780324
DOCNO: 10922963
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: complications
QUALIFIER: etiology
AUTHOR: J P Labat JP
AUTHOR: H Simon H
AUTHOR: J P Metges JP
AUTHOR: B Lucas B
AUTHOR: J P Malhaire JP
AFFILIATION: Fédération de Cancérologie, CHU - Hôpital Morvan, 5, avenue Foch, 29200 Brest. Jean-Paul.Labat@univ-brest.fr
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Annales de médecine interne.
COUNTRY: FRANCE
TITLE: [Pyoderma gangrenosum and breast cancer: a new case]
PUBDATE: 20000601
We report here a new case of pyoderma gangrenosum (PG) associated with a breast cancer in a 39-year-old woman. We only found in literature three other reports of this rare entity which seems usually to be associated with monoclonal gammopathy, gastro-intestinal diseases such as Crohn's disease, chronic ulcerative colitis, leukemias or rheumatologic diseases. A commun hapten between of tumor and skin may explain the origin of this inflammatory lesion. In our case, PG could be a paraneoplastic syndrome.


4. DOCID:25455 SCORE: 0.00140488348871843
DOCNO: 11516603
AUTHOR: S Krishna S
AUTHOR: V T Chang VT
AUTHOR: J A Shoukas JA
AUTHOR: J Donahoo J
AFFILIATION: Department of Medicine, University of Medicine and Dentistry New Jersey/New Jersey Medical School, Newark, NJ 07018, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Journal of pain and symptom management.
COUNTRY: United States
TITLE: Video-assisted thoracoscopic sympathectomy-splanchnicectomy for pancreatic cancer pain.
PUBDATE: 20010701
Patients with unresectable pancreatic cancer often suffer severe pain. Various techniques are available for pain control. We present a patient with pancreatic cancer who underwent unilateral video-assisted thoracoscopic sympathectomy-splanchnicectomy and had complete pain relief. This minimally invasive procedure offers promise in carefully selected patients with severe pain from pancreatic cancer and other conditions which are not amenable to conventional interventions.


5. DOCID:24927 SCORE: 0.00140487098426381
DOCNO: 11411565
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemistry
QUALIFIER: pharmacology
AUTHOR: P Magiatis P
AUTHOR: H Pratsinis H
AUTHOR: E Kalpoutzakis E
AUTHOR: A Konstantinidou A
AUTHOR: P Davaris P
AUTHOR: A L Skaltsounis AL
AFFILIATION: Department of Pharmacy, University of Athens, Greece.
PUBTYPE: Journal Article
JOURNALTITLE: Biological & pharmaceutical bulletin.
COUNTRY: Japan
TITLE: Hydrolyzable tannins, the active constituents of three Greek Cytinus taxa against several tumor cell lines.
PUBDATE: 20010601
Hydrolyzable tannins were found to be the active cytotoxic constituents of three Greek Cytinus taxa: Cytinus ruber, Cytinus hypocistis subsp. hypocistis and Cytinus hypocistis subsp. orientalis. The cytotoxic activity was evaluated against a broad spectrum of cancer cell lines. The structure of the active compounds was investigated with NMR and electrospray-MS/MS techniques.


6. DOCID:24957 SCORE: 0.00140487098414672
DOCNO: 11768872
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: blood
QUALIFIER: blood
PUBTYPE: Newspaper Article
JOURNALTITLE: TreatmentUpdate.
COUNTRY: Canada
TITLE: Looking at soluble CD23 levels to predict lymphoma.
PUBDATE: 20011001
As we noted in our first article on lymphoma, there isn't any quick and simple test to diagnose or predict which PHAs will develop this cancer. Nor are there any symptoms that specifically occur from having lymphoma. To try to remedy the situation, researchers in Italy have been monitoring levels of the a protein called soluble CD23 (sCD23) in the blood and fluid surrounding the brain--cerebrospinal fluid (CSF). They have found higher-than-normal levels of sCD23 in the CSF of PHAs who have brain lymphoma.


7. DOCID:24993 SCORE: 0.00111229804885103
DOCNO: 9927879
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Biopsy, Needle
DESCRIPTOR: Ultrasonography, Interventional
QUALIFIER: pathology
AUTHOR: P Meunier P
AUTHOR: Y Lebrun Y
AUTHOR: P Quatresooz P
AUTHOR: M Meurisse M
AUTHOR: A Beckers A
AFFILIATION: Service d'Imagerie médicale, Centre Hospitalier de l'Ardenne (Libramont-Ste Ode) et Polyclinique d'Oupeye.
PUBTYPE: Journal Article
JOURNALTITLE: Revue médicale de Liège.
COUNTRY: BELGIUM
TITLE: [How I study thyroid pathology using ultrasonography-guided needle biopsy]
PUBDATE: 19981201
From a retrospective study of 259 files, the authors stress the value of US-guided thyroid cytoponction and its essential role in case of thyroid cancer suspicion. This very specific and inexpensive method fits perfectly into the other exploration techniques. It is the deciding factor in the thyroid nodule differential diagnostic and therapeutic planning.


8. DOCID:25007 SCORE: 0.00111226245582239
DOCNO: 11043048
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Metaphor
DESCRIPTOR: Power (Psychology)
QUALIFIER: psychology
AUTHOR: B A Rix BA
AFFILIATION: H:S Bispebjerg Hospital, udviklings- og uddannelsesafdelingen.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Ugeskrift for laeger.
COUNTRY: DENMARK
TITLE: [Metaphors and power. A qualitative study of metaphorical thinking among Danish cancer patients]
PUBDATE: 20000901
The use of metaphors concerning cancer was investigated by interviewing nine Danish cancer patients, aged 30-85 years. Metaphors about the disease were widely used, e.g. personification metaphors. Most patients considered their cancer as a metaphor for a physical and psychological imbalance in the period before the disease. Some patients felt responsible for the disease. The metaphors of cancer patients should be considered when communicating with cancer patients.


9. DOCID:27738 SCORE: 0.00111200974896921
DOCNO: 9619108
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Plants, Medicinal
QUALIFIER: chemistry
QUALIFIER: isolation & purification
QUALIFIER: isolation & purification
AUTHOR: R X Tan RX
AUTHOR: W F Zheng WF
AUTHOR: H Q Tang HQ
AFFILIATION: Department of Biological Science & Technology, Nanjing University, P. R. China.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Planta medica.
COUNTRY: GERMANY
TITLE: Biologically active substances from the genus Artemisia.
PUBDATE: 19980501
Artemisia species, widespread in nature, are frequently utilized for the treatment of diseases such as malaria, hepatitis, cancer, inflammation, and infections by fungi, bacteria, and viruses. Furthermore, some Artemisia constituents were found to be potential insecticides and allelopathic chemicals. This genus is receiving growing attention presumably due to: (i) the diversified biology and chemistry of the constituents, (ii) the frequent application in traditional medical practice, and (iii) the rich source of the plant material. This review summarizes mainly the biological results obtained in the past decade. The significance and trends in this field are briefly discussed.


10. DOCID:25381 SCORE: 0.00110371743748188
DOCNO: 9523128
AUTHOR: R Oommen R
AUTHOR: M Curling M
AUTHOR: C Adams C
AUTHOR: E Barrett E
AUTHOR: E Titmuss E
AUTHOR: A Widdowson A
AFFILIATION: Royal Hospitals NHS Trust, Department of Cytopathology, St Bartholomew's Hospital, London.
PUBTYPE: Journal Article
JOURNALTITLE: Cytopathology : official journal of the British Society for Clinical Cytology.
COUNTRY: ENGLAND
TITLE: Evaluation of 40 x 22 mm coverslip area in cervical cancer screening.
PUBDATE: 19980201
Nine hundred and twenty-three smears covered by 40 x 22 mm size coverslips were examined inside and outside the coverslip area to determine whether this coverslip size could be responsible for missed dyskaryotic cells in conventional cervical cancer screening. There was no instance when abnormal cells seen outside the coverslip were not also present within the coverslipped area.


11. DOCID:25599 SCORE: 0.0010809817197004
DOCNO: 11018340
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: physiology
QUALIFIER: physiopathology
AUTHOR: R J Dunlop RJ
AUTHOR: C W Campbell CW
AFFILIATION: St. Christopher's Hospice, Esher, Surrey, United Kingdom.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Journal of pain and symptom management.
COUNTRY: UNITED STATES
TITLE: Cytokines and advanced cancer.
PUBDATE: 20000901
Cytokines have a major role in promoting the growth and spread of cancers. Elevated levels of several cytokines have been described in cancer patients. Evidence from animal and human studies suggests that cytokines may contribute to a wide range of symptoms in advanced cancer, including: asthenia, pain, drowsiness, cognitive failure, agitated delirium, autonomic dysfunction, anorexia, cachexia, fever and metabolic abnormalities. Considerable effort is being directed at finding anticytokine treatments, raising the possibility of new options for symptoms that are currently difficult to control.


12. DOCID:26054 SCORE: 0.000825600447124203
DOCNO: 10978897
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: metabolism
QUALIFIER: metabolism
QUALIFIER: metabolism
QUALIFIER: metabolism
AUTHOR: C P Blobel CP
AFFILIATION: Cellular Biochemistry and Biophysics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, Box 368, 1275 York Avenue, New York, New York 10021, USA. c-blobel@ski.mskcc.org
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Current opinion in cell biology.
COUNTRY: UNITED STATES
TITLE: Remarkable roles of proteolysis on and beyond the cell surface.
PUBDATE: 20001001
Proteolysis on the cell surface and in the extracellular matrix is essential for normal cellular functions during development and in the adult, but it may also have undesirable consequences, such as promoting cancer, arthritis, and Alzheimer's disease. Recent advances highlight the roles of zinc-dependent metalloproteinases (metzincins) in proper skeletal development, in activating EGF-receptor ligands, in Notch-dependent signaling, and in initiating and promoting tumorigenesis.


13. DOCID:27204 SCORE: 0.000825526411533466
DOCNO: 9860421
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: drug therapy
QUALIFIER: etiology
QUALIFIER: therapeutic use
QUALIFIER: therapeutic use
QUALIFIER: complications
AUTHOR: H Wurzer H
AUTHOR: I Schafhalter-Zoppoth I
AUTHOR: G Brandstätter G
AUTHOR: H Stranzl H
AFFILIATION: General Hospital of Graz, 2nd Medical Department, University Clinic of Surgery, Austria.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: The American journal of gastroenterology.
COUNTRY: UNITED STATES
TITLE: Hormonal therapy in chronic radiation colitis.
PUBDATE: 19981201
Severe gastrointestinal bleeding is a rare complication of radiation therapy that requires frequent transfusions. This case report describes a patient with severe bleeding from radiation colitis after treatment of bladder cancer. During 5 months of therapy with multiple drugs, the patient needed 26 units of packed red cells. A subsequent hormone therapy consisting of an estrogen-progesterone combination significantly reduced the need for blood transfusions and hospitalization. We conclude that hormones might provide a promising new additional symptomatic therapy for bleeding radiogenic colitis.


14. DOCID:27225 SCORE: 0.000825526406118216
DOCNO: 11103233
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
AUTHOR: M Fujii M
AUTHOR: M Kochi M
AUTHOR: F Mochizuki F
AFFILIATION: Dept. of Surgery III, Nihon University School of Medicine, Tokyo, Japan.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Gan to kagaku ryoho. Cancer & chemotherapy.
COUNTRY: JAPAN
TITLE: [Significance of neoadjuvant chemotherapy for gastric cancer]
PUBDATE: 20001101
Neoadjuvant chemotherapy for high-risk patients with advanced gastric cancer is important to increase the chance for curative resection and make unresectable gastric cancer tumors resectable by down-staging of the tumor. Tumors with H0, P0, T3, T4, or N3 are the best candidates for this therapy. Randomized controlled phase III studies are needed in conjunction with accurate staging of the disease by laparoscopy. The results of histopathologic evaluation of resected materials following preoperative chemotherapy using oral fluoropyrimidine are thought to be useful as an indicator of chemosensitivity for postoperative adjuvant setting.